Cargando…

Identification of prognostic signature in cancer based on DNA methylation interaction network

BACKGROUND: The identification of prognostic biomarkers for cancer patients is essential for cancer research. These days, DNA methylation has been proved to be associated with cancer prognosis. However, there are few methods which identify the prognostic markers based on DNA methylation data systema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Wei-Lin, Zhou, Xiong-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763425/ https://www.ncbi.nlm.nih.gov/pubmed/29322932 http://dx.doi.org/10.1186/s12920-017-0307-9

Ejemplares similares

Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Pengli, et al.
Publicado: (2022)

Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method
por: Cai, Qidong, et al.
Publicado: (2020)

Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer
por: Gao, Yinqi, et al.
Publicado: (2021)

Identification of DNA methylation prognostic signature of acute myelocytic leukemia
por: Zhang, Haiguo, et al.
Publicado: (2018)

DNA Methylation Data-Based Classification and Identification of Prognostic Signature of Children With Wilms Tumor
por: Tang, Fucai, et al.
Publicado: (2021)

A Novel Gene Prognostic Signature Based on Differential DNA Methylation in Breast Cancer
por: Zhu, Chunmei, et al.
Publicado: (2021)

Identification of 4-methylation driven genes based prognostic signature in thyroid cancer: an integrative analysis based on the methylmix algorithm
por: Chen, Zhiwei, et al.
Publicado: (2021)

DNA Methylation Module Network-Based Prognosis and Molecular Typing of Cancer
por: Cui, Ze-Jia, et al.
Publicado: (2019)

Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile
por: Zhang, Shumei, et al.
Publicado: (2022)

Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022)

WGCNA-Based DNA Methylation Profiling Analysis on Allopurinol-Induced Severe Cutaneous Adverse Reactions: A DNA Methylation Signature for Predisposing Drug Hypersensitivity
por: Cheng, Lin, et al.
Publicado: (2022)

Identification of prognostic signature of non–small cell lung cancer based on TCGA methylation data
por: Wang, Yifan, et al.
Publicado: (2020)

Identification of methylation sites and signature genes with prognostic value for luminal breast cancer
por: Xiao, Bin, et al.
Publicado: (2018)

DNA methylation signature is prognostic of choroid plexus tumor aggressiveness
por: Pienkowska, Malgorzata, et al.
Publicado: (2019)

Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer
por: Liu, Bangquan, et al.
Publicado: (2022)

Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma
por: Chen, Yuhua, et al.
Publicado: (2021)

Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
por: Sun, Hengzi, et al.
Publicado: (2019)

A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer
por: Xiao, Mingjia, et al.
Publicado: (2022)

DNA methylation signatures associated with prognosis of gastric cancer
por: Dai, Jin, et al.
Publicado: (2021)

Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer
por: Luo, Yongwen, et al.
Publicado: (2020)

Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes
por: Wang, Nan, et al.
Publicado: (2022)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

Correction to: DNA methylation signature is prognostic of choroid plexus tumor aggressiveness
por: Pienkowska, Malgorzata, et al.
Publicado: (2019)

A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
por: Li, Chunmei, et al.
Publicado: (2020)

Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene DAB2 as a Prognostic Biomarker in Differentiated Thyroid Carcinoma
por: Ju, Gaoda, et al.
Publicado: (2022)

Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
por: Luo, Wei-Ming, et al.
Publicado: (2018)

Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patients
por: Li, Xingchen, et al.
Publicado: (2020)

Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically
por: Men, Chuandi, et al.
Publicado: (2017)

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
por: Hu, Zhengang, et al.
Publicado: (2021)

Identification of DNA methylation signatures for hepatocellular carcinoma detection and microvascular invasion prediction
por: Hao, Yijie, et al.
Publicado: (2022)

Comprehensive Analysis of DNA Methylation and Transcriptome to Identify PD-1-Negative Prognostic Methylated Signature in Endometrial Carcinoma
por: Cao, Lu, et al.
Publicado: (2022)

The signature of liver cancer in immune cells DNA methylation
por: Zhang, Yonghong, et al.
Publicado: (2018)

A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis
por: Wang, Xiao-Wei, et al.
Publicado: (2021)

The Development of Three-DNA Methylation Signature as a Novel Prognostic Biomarker in Patients with Colorectal Cancer
por: Gong, Shu, et al.
Publicado: (2020)

A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer
por: Xu, Zhijie, et al.
Publicado: (2021)

Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma
por: Xiong, Xiaofeng, et al.
Publicado: (2023)

A Prognostic Model for Breast Cancer Based on Cancer Incidence-Related DNA Methylation Pattern
por: Xiong, Zhenchong, et al.
Publicado: (2022)

Identification of a Novel Prognostic Signature for Gastric Cancer Based on Multiple Level Integration and Global Network Optimization
por: Cui, Lin, et al.
Publicado: (2021)

A prognostic 11-DNA methylation signature for lung squamous cell carcinoma
por: Zhang, Jianlei, et al.
Publicado: (2020)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_58mbne2l9arn5424k8i477ktbj